Shanghai Chest Hospital — Biomedical Watch V2

Traitements4programmes

Essais2liés

Publications0liées

SourceDBlocale

Traitements

4

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided CryoablationThe purpose of the study is to evaluate the technical feasibility of 5G-enabled remote robotic-assisted bronchoscopy-guided cryoablation for pulmonary malignancies.	Cancer	Non applicable	À vérifier	China	À vérifier
Pulsed Field Ablation System and Single-Use Pulsed Field Ablation CatheterThis prospective, single-center, single-arm exploratory study will evaluate the safety and effectiveness of a pulsed field ablation system and a single-use pulsed field ablation catheter for the treatment of malignant lung tumors. Pulsed field ablation uses short electrical pulses to ablate targeted tumor tissue. The study plans to enroll 15 adult participants at Shanghai Chest Hospital. Each participant will undergo bronchoscopic pulsed field ablation and will be followed for 6 months after the procedure. The main outcome is the proportion of treated lesions showing complete ablation at 6 months. Technical success, tumor control, survival, quality of life, and adverse events will also be evaluated.	Cancer	Non applicable	À vérifier	China	À vérifier
5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided CryoablationThe purpose of the study is to evaluate the technical feasibility of 5G-enabled remote robotic-assisted bronchoscopy-guided cryoablation for pulmonary malignancies.	Cancer	Non applicable	À vérifier	China	À vérifier
Pulsed Field Ablation System and Single-Use Pulsed Field Ablation CatheterThis prospective, single-center, single-arm exploratory study will evaluate the safety and effectiveness of a pulsed field ablation system and a single-use pulsed field ablation catheter for the treatment of malignant lung tumors. Pulsed field ablation uses short electrical pulses to ablate targeted tumor tissue. The study plans to enroll 15 adult participants at Shanghai Chest Hospital. Each participant will undergo bronchoscopic pulsed field ablation and will be followed for 6 months after the procedure. The main outcome is the proportion of treated lesions showing complete ablation at 6 months. Technical success, tumor control, survival, quality of life, and adverse events will also be evaluated.	Cancer	Non applicable	À vérifier	China	À vérifier

Essais cliniques

2

Molécule	Indication / population	Phase	NCT	Titre	Statut
Pulsed Field Ablation System and Single-Use Pulsed Field Ablation Catheter	Cancer	Non applicable	NCT07889297	Pulsed Field Ablation for the Treatment of Malignant Lung Tumors	NOT_YET_RECRUITING
5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided Cryoablation	Cancer	Non applicable	NCT07830095	5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided Cryoablation for Pulmonary Malignancies	NOT_YET_RECRUITING

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.